$3.00
0.00%There's no data available for key stats
There's no data available for ratios/profitability stats
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
All You Need to Know About VistaGen Therapeutics Rating Upgrade to Buy
Does VistaGen Therapeutics, Inc. (VTGN) Have the Potential to Rally 160% as Wall Street Analysts Expect?
Immunocore Holdings PLC Sponsored ADR (IMCR) Moves 6.9% Higher: Will This Strength Last?
How Vistagen (VTGN) Stock Stands Out in a Strong Industry
Undervalued VistaGen Therapeutics, Analyst Highlights Potential In Anxiety Treatment
Anxiety-Focused Stock Vistagen Therapeutics Is An Undervalued Late-Stage Neurology Player: Analyst